Khloris Biosciences Khloris Biosciences is a biotechnology company developing the treatment of cardiovascular, oncology, and other diseases. | Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | Takeda Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. | Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |
Founding Date | Founding Date 2017 | Founding Date 2009 | Founding Date 1781 | Founding Date 2010 | Founding Date 2001 |
Type | Type Private | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Mountain View, US HQ | Locations Los Angeles, US HQ | Locations Gent, BE HQ | ||
Employees | Employees 1214% decrease | Employees 4843% increase | Employees 49,281 | Employees 27214% decrease | Employees 156 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 10.6 m | Valuation ($) 43.7 b | Valuation ($) 136.8 m | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) ¥4.3t (FY, 2024) | Revenue (est.) $235.6m (FY, 2023) | Revenue (est.) €85.2m (FY, 2016) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥698.7b (FY, 2024) | Cost of goods $62.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥3.6t (FY, 2024) | Gross profit $173m (FY, 2023) | Gross profit N/A |
Net income | Net income N/A | Net income ($264.5m) (FY, 2021) | Net income ¥144.2b (FY, 2024) | Net income $21.6m (FY, 2023) | Net income (€1.1m) (FY, 2016) |
Funding | |||||
Total funding raised | Total funding raised $ 5m | Total funding raised $ 357m | Total funding raised $ 57.8m | Total funding raised $ 172m | Total funding raised $ 498.8m |